366 related articles for article (PubMed ID: 23199967)
1. Therapy of human papillomavirus-related disease.
Stern PL; van der Burg SH; Hampson IN; Broker TR; Fiander A; Lacey CJ; Kitchener HC; Einstein MH
Vaccine; 2012 Nov; 30 Suppl 5(0 5):F71-82. PubMed ID: 23199967
[TBL] [Abstract][Full Text] [Related]
2. Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
Stanley M
J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955
[TBL] [Abstract][Full Text] [Related]
3. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
4. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.
Sun YY; Peng S; Han L; Qiu J; Song L; Tsai Y; Yang B; Roden RB; Trimble CL; Hung CF; Wu TC
Clin Cancer Res; 2016 Feb; 22(3):657-69. PubMed ID: 26420854
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Essahsah F; Fathers LM; Offringa R; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; van der Burg SH; Melief CJ
N Engl J Med; 2009 Nov; 361(19):1838-47. PubMed ID: 19890126
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
[TBL] [Abstract][Full Text] [Related]
8. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
9. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
Husein-ElAhmed H
Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccine update.
Gilmer LS
Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
[TBL] [Abstract][Full Text] [Related]
11. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
McCormack PL; Joura EA
Drugs; 2010 Dec; 70(18):2449-74. PubMed ID: 21142263
[TBL] [Abstract][Full Text] [Related]
12. [Consensus on HPV of the Portuguese Society of Andrology, Sexual Medicine and Reproduction: Treatment].
Jorge Pereira B; Graça B; Palmas A; Eufrásio P; Lebre A; Andrade P; Louro N; Azinhais P; Cardoso P; Tomada N; Vendeira P
Rev Int Androl; 2021; 19(3):150-159. PubMed ID: 32684426
[TBL] [Abstract][Full Text] [Related]
13. Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients.
Kawana K; Adachi K; Kojima S; Taguchi A; Tomio K; Yamashita A; Nishida H; Nagasaka K; Arimoto T; Yokoyama T; Wada-Hiraike O; Oda K; Sewaki T; Osuga Y; Fujii T
Vaccine; 2014 Oct; 32(47):6233-9. PubMed ID: 25258102
[TBL] [Abstract][Full Text] [Related]
14. Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
Garland SM; Paavonen J; Jaisamrarn U; Naud P; Salmerón J; Chow SN; Apter D; Castellsagué X; Teixeira JC; Skinner SR; Hedrick J; Limson G; Schwarz TF; Poppe WA; Bosch FX; de Carvalho NS; Germar MJ; Peters K; Del Rosario-Raymundo MR; Catteau G; Descamps D; Struyf F; Lehtinen M; Dubin G;
Int J Cancer; 2016 Dec; 139(12):2812-2826. PubMed ID: 27541373
[TBL] [Abstract][Full Text] [Related]
15. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
de Sanjosé S; Bruni L; Alemany L
Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review.
Pham CT; Juhasz M; Sung CT; Mesinkovska NA
J Am Acad Dermatol; 2020 Jan; 82(1):202-212. PubMed ID: 31085272
[TBL] [Abstract][Full Text] [Related]
17. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
18. The effect of high-risk HPV E6/E7 mRNA on the efficacy of topical photodynamic therapy with 5-aminolevulinic acid for cervical high-grade squamous intraepithelial lesions.
Zhang T; Zhang Y; Tang Y; Qin L; Shen Y; Wang B; Zhang L; Cao L; Zhou Y; Su Y; Wang L; Zhang M
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102974. PubMed ID: 35724936
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors.
Domingos-Pereira S; Galliverti G; Hanahan D; Nardelli-Haefliger D
J Immunother Cancer; 2019 May; 7(1):122. PubMed ID: 31060612
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
